clarithromycin has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerroni, L; João, A; Ponte, P; Serrão, V; Vale, E; Viana, I | 1 |
1 other study(ies) available for clarithromycin and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin.
Topics: Anti-Inflammatory Agents; Biomarkers, Tumor; Clarithromycin; Humans; Ki-1 Antigen; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms; Young Adult | 2011 |